Cointime

PharmEste

company

About

PharmEste s.r.l. is a biopharmaceutical company.

Highlights

Total Funding Amount
€4.80M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
€4.80M
Industries
Biopharma,Biotechnology,Therapeutics
Founded date
Jan 1, 2003
Operating Status
Close

PharmEste s.r.l., a biopharmaceutical company, engages in the discovery and development of transient receptor potential (TRP) channel therapeutics for the treatment of neuropathic pain, overactive bladder, and other TRP-mediated diseases. It develops PHE377, a TRPV1 antagonist for the treatment of neuropathic pain.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€4.80M
PharmEste has raised a total of €4.80M in funding over 2 rounds. Their latest funding was raised on Jun 1, 2011 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 1, 2011 Series B €4.80M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
—
1
PharmEste is funded by 1 investors. MPS Venture are the most recent investors.
Investor Name Lead Investor Funding Round
MPS Venture — Series B
Cointime
เนื้อหา
บริษัท